ProfileGDS4718 / 218767_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 83% 83% 85% 82% 91% 88% 86% 81% 84% 84% 80% 86% 89% 87% 83% 83% 85% 87% 85% 85% 84% 84% 83% 83% 90% 82% 84% 82% 86% 83% 87% 83% 83% 82% 84% 88% 86% 84% 83% 85% 85% 83% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4192384
GSM549102patient 115, normal, homogenized [OPG study]8.1458483
GSM549104patient 119, normal, homogenized [OPG study]8.3440983
GSM549108patient 138, normal, homogenized [OPG study]8.3442385
GSM549119patient 077, normal, homogenized [OPG study]8.0251782
GSM549133patient 032, cancer, homogenized [OPG study]9.5262391
GSM549139patient 042, cancer, homogenized [OPG study]8.8644688
GSM549099patient 107, normal, homogenized [OPG study]8.5286986
GSM549109patient 139, normal, homogenized [OPG study]7.9474881
GSM549110patient 046, normal, homogenized [OPG study]8.3225484
GSM549114patient 063, normal, homogenized [OPG study]8.4651284
GSM549122patient 082, normal, homogenized [OPG study]7.8774880
GSM549134patient 033, cancer, homogenized [OPG study]8.6040886
GSM549136patient 036, cancer, homogenized [OPG study]9.1082589
GSM549140patient 044, cancer, homogenized [OPG study]8.761987
GSM549111patient 047, normal, homogenized [OPG study]8.3164383
GSM549113patient 057, normal, homogenized [OPG study]8.4022683
GSM549132patient 031, cancer, homogenized [OPG study]8.4037185
GSM549137patient 038, cancer, homogenized [OPG study]8.690287
GSM549142patient 047, cancer, homogenized [OPG study]8.0387285
GSM549100patient 110, normal, homogenized [OPG study]8.4417285
GSM549107patient 135, normal, homogenized [OPG study]8.4113584
GSM549115patient 068, normal, homogenized [OPG study]8.4744584
GSM549116patient 072, normal, homogenized [OPG study]8.3085883
GSM549120patient 078, normal, homogenized [OPG study]8.200183
GSM549131patient 030, cancer, homogenized [OPG study]9.2178690
GSM549118patient 074, normal, homogenized [OPG study]8.1532482
GSM549129patient 027, cancer, homogenized [OPG study]8.2993684
GSM549123patient 088, normal, homogenized [OPG study]8.0744882
GSM549124patient 006, cancer, homogenized [OPG study]8.4579286
GSM549126patient 015, cancer, homogenized [OPG study]8.19283
GSM549128patient 025, cancer, homogenized [OPG study]8.7612487
GSM549103patient 117, normal, homogenized [OPG study]8.0604383
GSM549117patient 073, normal, homogenized [OPG study]8.2400483
GSM549138patient 041, cancer, homogenized [OPG study]8.1072682
GSM549141patient 045, cancer, homogenized [OPG study]8.5076684
GSM549130patient 028, cancer, homogenized [OPG study]8.7733888
GSM549101patient 111, normal, homogenized [OPG study]8.5817286
GSM549105patient 128, normal, homogenized [OPG study]8.2951284
GSM549106patient 134, normal, homogenized [OPG study]8.4287783
GSM549112patient 048, normal, homogenized [OPG study]8.507985
GSM549125patient 011, cancer, homogenized [OPG study]8.4599885
GSM549127patient 024, cancer, homogenized [OPG study]8.2084883
GSM549135patient 035, cancer, homogenized [OPG study]9.1851889